Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

TEM vs HQY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HQY Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

HQY Overall Winner 6-Pillar Tally: TEM 2 – 4 HQY Matrix Metrics: TEM 3 – 7 HQY

As of Nov 17, 2026, HealthEquity, Inc (HQY) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas HQY carries 41.2/100 (SELL) at $101.86 (23.0x Forward P/E, 26.1% operating margin).

  • Composite vs. Pillar Nuance: While TEM currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. HQY 41.2/100 SELL), HQY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (26.1% vs. -18.5% operating margin) and revenue trajectory (+7.6% vs. +23.1% YoY).
  • Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile HQY trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TEM vs HQY
TEM NASDAQ
Tempus AI, Inc. Class A Common Stock
Services-Computer Programming, Data Processing, Etc.
$63.08
-2.59% 1D
Market Cap $13.1B
TTM Revenue $1.51B
Forward P/E N/M
Beta / 30D Vol 2.51β · 93% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 51.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.3 · SMA20: $73.18 · SMA50: $72.83
HQY NASDAQ Head-to-Head Winner
HealthEquity, Inc
Services-Business Services, Nec
$101.86
-2.6% 1D
Market Cap $8.6B
TTM Revenue $1.36B
Forward P/E 23.0x
Beta / 30D Vol 0.28β · 38% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 39.0 Fund 45.0 Flow 65.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 54
RSI-14: 53.7 · SMA20: $102.82 · SMA50: $96.43

6-Pillar Scorecard Institutional Category Breakdown (TEM 2 – 4 HQY)

Columns: Metric · TEM · HQY
1. Valuation Multiples HQY
Forward P/E N/M 23.0x
Trailing P/E N/M 37.4x
PEG Ratio N/M 1.27x
EV / Revenue 9.2x 6.8x
2. Growth & Scale TEM
Revenue Growth (YoY) +23.1% +7.6%
Earnings Growth (YoY) +0.0% +14.7%
TTM Revenue (USD) $1.51B $1.36B
Market Cap $13.1B $8.6B
3. Profitability & Quality HQY
Gross Margin 64.5% 71.2%
Operating Margin -18.5% 26.1%
Net Profit Margin -12.5% 17.4%
Return on Equity (ROE) -37.5% 11.4%
4. Balance Sheet & Cash Flow HQY
Cash Generation (TTM) -$151M $437M
Cash Flow Margin -10.0% 32.1%
Net Cash / Leverage $841M Net Debt (2.86x D/E) $715M Net Debt (0.49x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HQY
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 99.3% (44th %ile) 35.8% (12th %ile)
Put/Call OI Skew 0.49x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat TEM
OpEx & R&D Intensity 83.0% of Rev ($1.25B) 45.1% of Rev ($614M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Ecosystem & Network-Effect Moat Scale & Operating Efficiency Moat
Supply-Chain Role Health Information Services Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TEM (3) vs HQY (7)
Institutional Metric TEM HQY Criterion Row Edge
Market Capitalization
Scale
$13.1B $8.6B Larger Scale TEM
Trailing P/E Ratio
Valuation
N/M 37.4x Lower Multiple HQY
Forward P/E Ratio
Valuation
N/M 23.0x Lower Multiple HQY
Revenue Growth (YoY)
Growth
+23.1% +7.6% Higher Growth TEM
Operating Margin (TTM)
Profitability
-18.5% 26.1% Higher Margin HQY
Net Profit Margin
Profitability
-12.5% 17.4% Higher Margin HQY
Return on Equity (ROE)
Capital Efficiency
-37.5% 11.4% Higher ROE HQY
52-Week Range Position
Momentum
46% ($41–$89) 78% ($73–$110) Stronger Trend HQY
Beta / 30D Volatility
Risk Regime
2.51β · 93% Vol 0.28β · 38% Vol Lower Realized Risk HQY
Unified Institutional Score
Composite Signal
43.5 / 100 (HOLD) 41.2 / 100 (SELL) Higher Composite TEM
Trailing 12M Revenue (USD)
Operating Scale
$1.51B $1.36B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.5% 71.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.2x EV/Rev 1.27x PEG · 6.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$151M ($841M Net Debt (2.86x D/E)) $437M ($715M Net Debt (0.49x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HQY +11.41 pp
TEM: -1.96% · HQY: +9.45%
3M Horizon TEM +5.0 pp
TEM: +2.99% · HQY: -2.01%
6M Horizon TEM +18.21 pp
TEM: +38.55% · HQY: +20.34%
1Y Horizon HQY +7.98 pp
TEM: -7.89% · HQY: +0.09%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period TEM Revenue HQY Revenue TEM Op. Margin HQY Op. Margin Margin Leader
FY2019 N/A $290M N/A 27.0% HQY
FY2020 N/A $530M N/A 14.5% HQY
FY2021 N/A $730M N/A 4.6% HQY
FY2022 $320M $760M -82.8% -3.2% HQY
FY2023 $530M $860M -36.9% 1.1% HQY
FY2024 $690M $1.00B -99.7% 11.8% HQY
FY2025 $1.27B $1.20B -19.9% 13.5% HQY
FY2026 N/A $1.31B N/A 24.6% HQY

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TEM BREAKDOWN
36d in phase · OBV DISTRIBUTION
Current IV 99.3%
IV Percentile 44th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact TEM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HQY CONSOLIDATION
74d in phase · OBV NEUTRAL
Current IV 35.8%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HQY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $64.76 · IV 84.1%

TEM Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,476)

Compare $6,476 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 84.1% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $65 / $75 Bull Call Spread

Buy 1x $65C · Sell 1x $75C · 32d

Net Entry $365 Debit
T+5d @ +5% Move +$69 (+19%)
Max Risk / Buffer $365 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $60 / $55 Bull Put Spread

Sell 1x $60P · Buy 1x $55P · 32d

Net Entry $160 Credit
Max Credit / Yield +$160 (+47.1% RoM)
Max Risk / Buffer -9.8% Cushion ($340 Mgn)
5d Edge & Liquidity 68% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $55P / $70-$80C Seagull

Sell 1x $55P · Buy 1x $70/$80C · 32d

Net Entry $53 Debit
T+5d @ +5% Move +$151 (+18.8% RoM)
Max Risk / Buffer -15.1% Put Cushion ($803 Mgn)
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TEM Moat Profile Ecosystem & Network-Effect Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $13.1B market capitalization and -18.5% operating margin.
OpEx & R&D Reinvestment 83.0% of Rev ($1.25B)
90D Engineering Disclosures 0 Published · AI Drug Discovery
HQY Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $8.6B market capitalization and 26.1% operating margin.
OpEx & R&D Reinvestment 45.1% of Rev ($614M)
90D Engineering Disclosures 0 Published

Investor FAQ TEM vs HQY Key Questions & Quantitative Answers

As of Nov 17, 2026, HealthEquity, Inc (HQY) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). TEM carries a Unified Composite Score of 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin), whereas HQY carries 41.2/100 (SELL) at $101.86 (23.0x Forward P/E, 26.1% operating margin). Composite vs. Pillar Nuance: While TEM currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. HQY 41.2/100 SELL), HQY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (26.1% vs. -18.5% operating margin) and revenue trajectory (+7.6% vs. +23.1% YoY). Technical & Structure Timing Caution: TEM is currently in a Breakdown options structure phase (RSI 40.3); meanwhile HQY trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TEM leads the Growth & Scale pillar: TEM posts +23.1% YoY revenue growth and +0.0% YoY earnings growth on $1.51B TTM revenue (64.5% gross margin, -18.5% operating margin), compared with HQY at +7.6% YoY revenue growth and +14.7% YoY earnings growth on $1.36B TTM revenue (71.2% gross margin, 26.1% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), TEM cumulative revenue shifted +296.9% while HQY shifted +351.7%. In operating R&D and SG&A reinvestment, TEM deploys 83.0% of Rev ($1.25B) (0 90-day corporate R&D disclosures) versus 45.1% of Rev ($614M) (0 disclosures) for HQY.

HQY screens cheaper on headline valuation multiples. TEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-10.0% FCF margin), whereas HQY trades at 23.0x Forward P/E, 37.4x Trailing P/E, 1.27x PEG, and 6.8x EV/Revenue (32.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TEM (-37.5% ROE) versus HQY (11.4% ROE) capital efficiency.

In options market volatility and institutional positioning, TEM carries 99.3% implied volatility (44th %ile, Balanced (25th–60th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.51β · 93% Vol realized risk). By comparison, HQY carries 35.8% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.28β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.